Helper T cell recognition of antigen requires that the antigen be processed and presented by MHC class II expressing antigen presenting cells such as B cells and macrophages. For B cells, processing is initiated by antigen binding to the surface Ig. The antigen is internalized into acidic compartments, and proteolyzed to yield peptide fragments which bind to the class II molecules and are subsequently expressed on the cell surface. Processing and presentation of antigen is an early, critical event in the initiation of T cell-dependent antibody responses. The ability of B cells to produce a sufficient number of processed antigen-class II complexes and express these on their surface for a sufficient period of time will determine if helper T cells can be attracted and activated to provide the necessary helper functions. This proposal represents an approach to further delineate the cellular and molecular mechanisms underlying antigen processing and presentation in B cells. Over the last granting period an important advance was achieved in the isolation of subcellular vesicles in which processed-antigen class II complexes are assembled following Ig-mediated internalization of antigen. These vesicles represent extremely valuable material for subsequent study.
Four specific aims are proposed: 1) To continue the characterization of the processing vesicles in terms of their content and microenvironment using both biochemical and serological assays as well as immunoelectron microscopy; 2) To determine which surface molecules have access to these compartments; 3) To define the role of the surface Ig in facilitating and regulating antigen processing events and 4) To evaluate the effect of targeting antigen to IgD-expressing B cells in vivo. Knowledge gained through the proposed studies will be important in guiding the design of therapeutics which block the inappropriate processing or presentation of antigen as is likely to occur in autoimmune disease and in the design of peptide based vaccines.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI027957-08
Application #
2003561
Study Section
Immunobiology Study Section (IMB)
Project Start
1990-01-01
Project End
1999-12-31
Budget Start
1997-01-01
Budget End
1997-12-31
Support Year
8
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Biochemistry
Type
Schools of Arts and Sciences
DUNS #
City
Evanston
State
IL
Country
United States
Zip Code
60201
Cheng, P C; Brown, B K; Song, W et al. (2001) Translocation of the B cell antigen receptor into lipid rafts reveals a novel step in signaling. J Immunol 166:3693-701
Sproul, T W; Malapati, S; Kim, J et al. (2000) Cutting edge: B cell antigen receptor signaling occurs outside lipid rafts in immature B cells. J Immunol 165:6020-3
Wagle, N M; Kim, J H; Pierce, S K (1999) CD19 regulates B cell antigen receptor-mediated MHC class II antigen processing. Vaccine 18:376-86
Cheng, P C; Dykstra, M L; Mitchell, R N et al. (1999) A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J Exp Med 190:1549-60
Cheng, P C; Steele, C R; Gu, L et al. (1999) MHC class II antigen processing in B cells: accelerated intracellular targeting of antigens. J Immunol 162:7171-80
Wagle, N M; Faassen, A E; Kim, J H et al. (1999) Regulation of B cell receptor-mediated MHC class II antigen processing by FcgammaRIIB1. J Immunol 162:2732-40
Schafer, P H; Malapati, S; Hanfelt, K K et al. (1998) The assembly and stability of MHC class II-(alpha beta)2 superdimers. J Immunol 161:2307-16
Wagle, N M; Kim, J H; Pierce, S K (1998) Signaling through the B cell antigen receptor regulates discrete steps in the antigen processing pathway. Cell Immunol 184:1-11
Song, W; Wagle, N M; Banh, T et al. (1997) Wortmannin, a phosphatidylinositol 3-kinase inhibitor, blocks the assembly of peptide-MHC class II complexes. Int Immunol 9:1709-22
Schafer, P H; Green, J M; Malapati, S et al. (1996) HLA-DM is present in one-fifth the amount of HLA-DR in the class II peptide-loading compartment where it associates with leupeptin-induced peptide (LIP)-HLA-DR complexes. J Immunol 157:5487-95

Showing the most recent 10 out of 26 publications